ロード中...
The Identification of Immunological Biomarkers in Kidney Cancers
The recent approval of several agents have revolutionized the scenario of therapeutic management of metastatic renal cell carcinoma (RCC) allowing us to reach important clinical end points with extended patients' survival. Actually, every new drug approved has represented an important step forw...
保存先:
| 出版年: | Front Oncol |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6225533/ https://ncbi.nlm.nih.gov/pubmed/30450335 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2018.00456 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|